Web of Science data analyzes G20 nations as a driver for
innovation plus a special analysis of members' contribution to
recent COVID-19 research
LONDON, Nov. 11, 2020 /PRNewswire/ -- Clarivate Plc
(NYSE:CCC), a global leader in providing trusted information and
insights to accelerate the pace of innovation, today launched a new
report which examines the research performance of the G20 with a
visual comparative snapshot for each member nation. It also
includes a special analysis of the G20 members' contribution to
recent COVID-19 research as indexed in the Web of Science™ research
publication and citation index.
The report, The Annual G20 Scorecard – Research Performance 2020
has been created by the Institute for Scientific Information™ at
Clarivate ahead of this year's G20 Summit, which will be hosted
virtually by Riyadh, Saudi Arabia
on November 21-22. It includes both a
written summary and a host of graphs and exhibits that highlight
the research performance of Argentina, Australia, Brazil, Canada, China, France, Germany, India, Indonesia, Italy, Japan,
Mexico, Russia, Saudi
Arabia, South Africa,
South Korea, Turkey, United
Kingdom and the United
States.
The G20 is a group of 19 leading economies, with the EU as the
additional 20th member. Collectively the 19 countries of the G20
represent two-thirds of the world's population, produce 81% of
global GDP, spend 92% of global R&D, employ 87% of the world's
researchers and publish 86% of the global research papers indexed
in the Web of Science with more than five million articles and
reviews indexed for the last three years.
Our report shows that – due to their relatively developed
research bases – G20 nations have been the most active participants
in COVID-19 research, and it has been particularly relevant for the
highly populated G20 member nations which also report some of the
highest absolute number of reported cases: United States, India, Brazil
and Russia.
Jonathan Adams, Director at
the Institute for Scientific Information at Clarivate and
a co-author of this annual report said: "The G20 meeting is one of
the world's few forums for international co-operation this year and
expectations are rightly high that the expertise and resources of
its members should play a champion's role in addressing the
pandemic challenge. This should produce a rapid understanding of
the biological issues, the health impacts and responses, the social
outcomes and the economic and societal implications of a pandemic.
This year especially, these scorecards will help policymakers,
observers and reporters to track, applaud and critique the research
progress of the G20 member nations."
Researchers across the globe have been engaged in basic,
experimental and clinical studies to understand the virus and,
ultimately produce a vaccine and/or a cure. The published
literature has rapidly increased at an unprecedented scale and
through the examination of the text in the titles, abstracts and
keywords of more than 18,000 articles and reviews indexed in the
Web of Science since January 2020,
ISI identified clusters of COVID-19 research topics and analyzed
each G20 nation's contribution as well as the topical spread across
the group.
The national research profiles within the report are selective,
highlighting chosen topics of current policy interest that identify
good signals of the health of the research base for each member
country of the G20. Key factors that contribute to impactful
research are laid out for each nation in the report and
benchmarked.
Some key findings include:
- In Australia output has
doubled in a decade and continues to rise, driven by exceptional
international collaboration.
- China boasts an
enormous research workforce and a large volume of investment (more
than two million researchers, GERD over 2% GDP) and patents/BERD is
twice that of any other G20 country.
- In Germany investment
is higher than EU neighbors, with GERD over 3% of GDP. Output per
researcher is around G20 average. However, only 28% of researchers
are female and Open Access is below G20 average.
- In Indonesia research
output is small and domestic output is only 20% of the total, but
volume has trebled since 2010, in all disciplines.
- For researchers in Mexico, citation impact is relatively good
in all areas although output is only just above G20 median.
Productivity per GERD is well above G20 average, so output has not
been constrained by consistently low government investment.
- There is consistently high Open Access across disciplines in
South Africa and the
country has the second highest frequency of female researchers
(43%).
- For the United Kingdom,
the share of papers in the global top 10% is the highest in the G20
and the Impact Profile shows that the domestic research base
performs well above group average. International collaboration is
exceptionally high, and rising, for such a large economy. The
number of female researchers (39%) is above G20 average.
- In the United States,
although investment is high, output is declining, and
output/researcher has fallen below the G20 average.
Joel Haspel, SVP Strategy,
Science at Clarivate said: "The world's most prosperous
economies are also among the most innovative and that innovation is
driven first and foremost by research. The Institute for Scientific
Information is uniquely placed to analyze and report on the
comparative health of the research landscape for each G20 nation,
setting Web of Science data alongside other key metrics on people,
finance and patenting alongside each member's contribution to the
recent papers addressing the pandemic."
The full report is freely available here:
https://clarivate.com/webofsciencegroup/campaigns/the-annual-2020-scorecard-research-performance-2020
Notes to editors:
Follow the conversation on Twitter
@WebofScience #InstituteSciInfo #G20
About Clarivate
Clarivate™ is a global leader in
providing solutions to accelerate the lifecycle of innovation. Our
bold mission is to help customers solve some of the world's most
complex problems by providing actionable information and insights
that reduce the time from new ideas to life-changing inventions in
the areas of science and intellectual property. We help customers
discover, protect and commercialize their inventions using our
trusted subscription and technology-based solutions coupled with
deep domain expertise. For more information, please visit
clarivate.com.
About the Institute for Scientific Information
The
Institute for Scientific Information (ISI)™ at Clarivate has
pioneered the organization of the world's research information for
more than half a century. Today it remains committed to promoting
integrity in research whilst improving the retrieval,
interpretation and utility of scientific information and maintains
the knowledge corpus upon which the Web of Science™ index and
related information and analytical content and services are built.
It disseminates that knowledge externally through events,
conferences and publications whilst conducting primary research to
sustain, extend and improve the knowledge base. For more
information, please visit
https://clarivate.com/webofsciencegroup/solutions/isi-institute-for-scientific-information/
Media Contact
Rebecca
Krahenbuhl
media.enquiries@clarivate.com